Albert J Arias, Carole Siegel, Eugene Laska, Joseph Wanderling, Brendan Ho, Richard Feinn, Rachel L Kember, Hang Zhou, Ziqiang Lin, Heng Xu, Andrew Snyder, Olivia R Nicastro, Nidhi Desai, Ismene L Petrakis, Jonathan M Covault, Joel Gelernter, Joanna Biernacka, Yuna Kim, Viktor Karpyak, Charles R Marmar, Henry R Kranzler
{"title":"Polygenic risk scores as predictors of topiramate's effect in treating alcohol use disorder.","authors":"Albert J Arias, Carole Siegel, Eugene Laska, Joseph Wanderling, Brendan Ho, Richard Feinn, Rachel L Kember, Hang Zhou, Ziqiang Lin, Heng Xu, Andrew Snyder, Olivia R Nicastro, Nidhi Desai, Ismene L Petrakis, Jonathan M Covault, Joel Gelernter, Joanna Biernacka, Yuna Kim, Viktor Karpyak, Charles R Marmar, Henry R Kranzler","doi":"10.1093/alcalc/agag064","DOIUrl":"10.1093/alcalc/agag064","url":null,"abstract":"<p><strong>Introduction: </strong>Topiramate is efficacious for treating alcohol use disorder (AUD), but treatment response varies considerably. To advance precision treatment, we used machine-learning methods integrating clinical trial and genetic data to estimate expected response to topiramate.</p><p><strong>Methods: </strong>Random forest (RF) regression models were used to estimate expected topiramate response using randomized clinical trial data from 278 participants and 23 pre-treatment features: four alcohol polygenic risk scores (PRS), nine alcohol drinking measures, and 10 clinical and sociodemographic variables. RF importance scores quantified each feature's contribution to predictive performance. Likely Responders (LRs) were identified using quintiles of predicted treatment response and counterfactual placebo response, with LRs defined as quintiles in which randomized trial data demonstrated topiramate superiority over placebo. Variable Selection Using Random Forests (VSURF) was used to eliminate less informative and redundant predictors.</p><p><strong>Results: </strong>Two pre-treatment drinking measures consistently had the highest importance scores across all VSURF levels. The final parsimonious model retained three predictors: average drinks per day, percent heavy drinking days, and the PRS for \"Time Until Relapse,\" with bias-corrected R2 = 0.30. LRs comprised the top four predicted response quintiles (80% of the sample) across models. Compared with unlikely responders, LRs had lower baseline drinking severity and higher \"Time Until Relapse\" PRS.</p><p><strong>Conclusions: </strong>The \"Time Until Relapse\" PRS contributed meaningfully to estimating expected response, LR stratification, and observed topiramate treatment effects, although pre-treatment drinking measures remained the strongest predictors. These findings support incorporation of pharmacogenomic markers into machine-learning models to advance precision prescribing for AUD.</p>","PeriodicalId":7407,"journal":{"name":"Alcohol and alcoholism","volume":"61 6","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13630443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149102902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jimikaye B Courtney, Ishrat Z Alam, Kelly R Evenson
{"title":"Physical activity reduces but does not fully counteract the detrimental associations between alcohol use and metabolic syndrome.","authors":"Jimikaye B Courtney, Ishrat Z Alam, Kelly R Evenson","doi":"10.1093/alcalc/agag066","DOIUrl":"https://doi.org/10.1093/alcalc/agag066","url":null,"abstract":"<p><strong>Background: </strong>This cross-sectional study investigated the main and interacting associations of physical activity (PA) and alcohol use with the number of metabolic syndrome (MetS) risk factors and odds of MetS.</p><p><strong>Methods: </strong>We used 2011-2014 (N = 3227) and 2015-2020 (N = 5586) National Health and Nutrition Examination Survey data for adults (20-80 years). We categorized participants into quartiles for device-based PA (2011-2014) and meeting or not meeting recommendations (≥150 vs <150 min of PA/week) for self-reported PA (2015-2020). We calculated average self-reported drinks/day. MetS risk factors were: (1) waist circumference ≥88/≥102 cm for females/males; (2) triglycerides ≥150 mg/dl; (3) blood pressure ≥130 mm Hg/≥85 mm Hg; (4) fasting glucose ≥100 mg/dl; and (5) high-density lipoprotein cholesterol (HDL-C) <50/<40 mg/dl for females/males. We categorized participants with MetS if they had ≥3 risk factors. We examined the direct and moderating associations of PA and alcohol use with number of MetS risk factors and odds of MetS.</p><p><strong>Results: </strong>Compared to Q1, adults in Q2-Q4 had fewer MetS risk factors (Q2: incidence rate ratio [IRR] = 0.90, 95% confidence interval [CI]: 0.84, 0.97; Q3: IRR = 0.80, 95% CI: 0.74, 0.87; Q4: IRR = 0.73, 95% CI: 0.67, 0.80). Compared to Q1, adults in Q3 and Q4 had lower odds of MetS when consuming ≤0.50 drinks/day (odds ratio [OR] = 0.44, 95%CI: 0.30, 0.64) or ≤0.75 drinks/day (OR = 0.43, 95%CI: 0.30, 0.60), respectively. Meeting PA recommendations was associated with fewer risk factors (IRR = 0.90, 95%CI: 0.84, 0.96). CIs were wide for some estimates due to sparsity of data at higher alcohol levels.</p><p><strong>Conclusions: </strong>Adults should consider engaging in more PA and limiting their alcohol use to reduce risk factors and overall MetS risk.</p>","PeriodicalId":7407,"journal":{"name":"Alcohol and alcoholism","volume":"61 6","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149102814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nagabhushana Amruthavarshini, Gayathiri Kaduveti Chellaiya, Santhosh E Kumar, Dolly Daniel, Vinoi George David, Suceena Alexander, Santosh Varughese, Nitin Kapoor, Sunderraj Gnanadeepam, Sumathy Jayaraman, Babuji Manimegalai, Kausala Sithamparapillai, Uday George Zachariah, Chundamannil E Eapen, Ashwani K Singal, Ashish Goel
{"title":"In alcohol-related acute on chronic liver failure survival after plasma exchange and low-dose steroid is associated with improvement in nutritional parameters and quality of life.","authors":"Nagabhushana Amruthavarshini, Gayathiri Kaduveti Chellaiya, Santhosh E Kumar, Dolly Daniel, Vinoi George David, Suceena Alexander, Santosh Varughese, Nitin Kapoor, Sunderraj Gnanadeepam, Sumathy Jayaraman, Babuji Manimegalai, Kausala Sithamparapillai, Uday George Zachariah, Chundamannil E Eapen, Ashwani K Singal, Ashish Goel","doi":"10.1093/alcalc/agag069","DOIUrl":"https://doi.org/10.1093/alcalc/agag069","url":null,"abstract":"<p><strong>Aims: </strong>Plasma exchange (PLEX) and low-dose steroid improve survival in alcohol-related acute on chronic liver failure (A-ACLF) patients. In this study, we aimed to objectively assess its effect on nutritional parameters and quality of life (QoL) in survivors.</p><p><strong>Methods: </strong>Alcohol-related ACLF (as defined by Asia Pacific Association of Study of Liver) patients treated with PLEX and low-dose steroid (August 2023-May 2025) were serially assessed prospectively for nutritional status, anthropometry, sarcopenia, frailty, and QoL. Centrifugal low-volume PLEX, with low-dose steroid was done as per protocol (PMID: 37975044).</p><p><strong>Results: </strong>Forty-eight A-ACLF patients [males: 48; age: 40 (27-68) years; median (range); discriminant function: 103 (43-206); MELD score: 31 (22-50)] treated with PLEX and low-dose steroids were studied. At baseline, all 48 patients had malnutrition (severe: 15, moderate: 27, mild: 6), the majority had sarcopenia (38 patients, 79%), were frail [42 patients, 87.5%; liver frailty index (LFI): 4.9 (4.3-6.7)], and had poor QoL [Chronic Liver Disease Questionnaire (CLDQ): 3.4 (2.6-4.3)].On follow-up (3-6 months, n = 25), there was improvement in nutritional parameters-nutrition status [moderate-severe impaired nutrition: 19 patients (76%) to 9 (36%), P-value < .02]; hand grip strength [19.4 (7.6-31) kg to 21.5 (8.7-31.3) kg, P-value .012]; muscle mass [skeletal muscle index: 6.3 (2.7-7.4) to 6.9 (4.2-8.8), P-value .05]; severe sarcopenia [20 (80%) to 7 (28%), P-value .001]; frailty [LFI: 4.7 (4.3-6.1) to 4.5 (3.5-6.6), P-value < .001]; QoL [CLDQ: 3.5 (2.6-4.4) to 5.7 (3.5-6.8), P-value <.001]; and MELD: 30 (23-43) to 17 (7-30); P-value: .05; at baseline and at follow-up, respectively. ACLF reversal was observed in 9/25 (36%) patients.</p><p><strong>Conclusions: </strong>In A-ACLF patients, survival after PLEX and low-dose steroid is associated with improvement in nutritional parameters and QoL.</p>","PeriodicalId":7407,"journal":{"name":"Alcohol and alcoholism","volume":"61 6","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149284672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Madeline B Benz, Siqi Li, Brandon A Gaudiano, Ted R Miller
{"title":"Alcohol-involved suicide mortality prevalence estimates and identification of co-occurring substance use from the National Violent Death Reporting System, 2022-2023.","authors":"Madeline B Benz, Siqi Li, Brandon A Gaudiano, Ted R Miller","doi":"10.1093/alcalc/agag065","DOIUrl":"https://doi.org/10.1093/alcalc/agag065","url":null,"abstract":"<p><p>Using National Violent Death Reporting System data (2022-2023), 14 909 suicide decedents (34%) tested positive for alcohol. The most common substances co-occurring with alcohol were marijuana, antidepressants, opioids, and benzodiazepines; polysubstance use was high, with 52% testing positive for alcohol and ≥1 other substance. Findings suggest an overall alcohol-involved suicide mortality rate of 24%, appearing higher than prior estimates.</p>","PeriodicalId":7407,"journal":{"name":"Alcohol and alcoholism","volume":"61 6","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149172074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pharmacological interventions for alcohol use disorder on quality of life: a meta-analysis of randomized controlled trials.","authors":"Dimy Fluyau, Neelambika Revadigar, Paul Kim","doi":"10.1093/alcalc/agag067","DOIUrl":"10.1093/alcalc/agag067","url":null,"abstract":"<p><strong>Aims: </strong>Quality of life (QoL), a critical factor for sustaining recovery from alcohol use disorder (AUD), has been examined as an AUD-related outcome in randomized controlled trials (RCTs) that evaluated pharmacotherapy for AUD. This review evaluates the efficacy of this therapy in improving mental and physical health-related QoL.</p><p><strong>Methods: </strong>RCTs were identified across seven databases. Study quality was evaluated using the Cochrane risk-of-bias tool for randomized trials version 2. A systematic review with meta-analysis was conducted. The review adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines and was registered with PROSPERO (CRD420261277890).</p><p><strong>Results: </strong>Eighteen RCTs with 4376 participants were evaluated. Naltrexone was linked to improvements in both mental QoL (d = 0.30, 95% CI: 0.08-0.52) and physical QoL (d = 0.16, 95% CI: 0.01-0.31). Nalmefene improved physical QoL (d = 0.13, 95% CI: 0.02-0.25) but not mental QoL (d = 0.18, 95% CI: -0.004 to 0.354). Topiramate showed no improvement in either domain. However, further analysis indicated that topiramate was associated with a small improvement in physical QoL, which could correlate with a reduced percentage of heavy drinking days. Interpret these findings with caution. Acamprosate, sertraline, and psilocybin were associated with improved mental or physical QoL, whereas ketamine, varenicline, levetiracetam XR, and quetiapine were not. Interpretation is limited to single trials-no eligible RCTs reporting the specified QoL outcomes for disulfiram.</p><p><strong>Conclusions: </strong>Certain medications for AUD are linked with improved mental and physical QoL, but evidence remains limited. Future RCTs should assess QoL and establish whether improvements are clinically meaningful.</p>","PeriodicalId":7407,"journal":{"name":"Alcohol and alcoholism","volume":"61 6","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149102896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ellen McGuire, Tristan Hurzeler, Warren Logge, Joshua Watt, Iain S McGregor, Anastasia Suraev, Paul S Haber, Kirsten C Morley
{"title":"Effects of cannabidiol on risky decision-making and autonomic function in alcohol use disorder.","authors":"Ellen McGuire, Tristan Hurzeler, Warren Logge, Joshua Watt, Iain S McGregor, Anastasia Suraev, Paul S Haber, Kirsten C Morley","doi":"10.1093/alcalc/agag068","DOIUrl":"10.1093/alcalc/agag068","url":null,"abstract":"<p><strong>Aims: </strong>To examine the effects of cannabidiol (CBD) on psychophysiological responding and risky decision-making in individuals with alcohol use disorder (AUD).</p><p><strong>Methods: </strong>In a double-blind, placebo-controlled crossover trial, 18 participants with AUD completed the Columbia Card Task (CCT) following administration of CBD and placebo. Skin conductance responses (SCR) and high-frequency heart rate variability (HF-HRV) were assessed as indices of autonomic responding during task performance. Risk-taking was indexed by the number of cards selected on the CCT.</p><p><strong>Results: </strong>CBD did not significantly affect SCR (P = .16, pBH = .326) or risky decision-making on the CCT (P > .63, pBH = 0.67). However, CBD significantly increased HF-HRV (β = 0.53, SE = 0.19, P = .005; pBH = 0.020). There was no evidence that the relationships between HF-HRV or SCR and risky decision-making differed between CBD and placebo conditions (drug × HF-HRV: P = .92; drug × SCR: P = .958; both pBH = .958).</p><p><strong>Discussion: </strong>CBD increased HF-HRV but did not significantly alter SCR, risky decision-making, or the relationship between autonomic responses and risky decision-making. These findings suggest that CBD influences autonomic responding during task performance, although the functional significance of this effect remains uncertain. The modest sample size and relatively healthy, non-treatment-seeking sample may have limited the ability to detect broader physiological and behavioural effects.</p>","PeriodicalId":7407,"journal":{"name":"Alcohol and alcoholism","volume":"61 6","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13665463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149178759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Risk of congenital genitourinary abnormalities in offspring and parental alcohol consumption during the periconception period: a systematic review and meta-analysis.","authors":"Huimei Cao, Jing Du, Yu Chen","doi":"10.1093/alcalc/agag071","DOIUrl":"10.1093/alcalc/agag071","url":null,"abstract":"<p><strong>Aim: </strong>To clarify the association between parental alcohol consumption and congenital genitourinary abnormalities (CGAs) in offspring.</p><p><strong>Methods: </strong>Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines, we conducted a systematic review and meta-analysis of cohort and case-control studies to examine the association between parental alcohol consumption during the periconception period and the risk of CGAs and its phenotypes, and to explore potential dose-response patterns. This review was not registered in PROSPERO.</p><p><strong>Results: </strong>Twenty-seven studies involving 52 285 malformed cases and 121 772 controls were included. Maternal alcohol consumption was associated with lower odds of cryptorchidism (OR 0.87, 95% CI 0.80-0.95, P = .001) and higher odds of hypospadias (OR 1.16, 95% CI 1.08-1.26, P < .001), but the association was not significant when the phenotypes were pooled (OR 1.03, P = .55). In the dose-response analysis, the association between maternal alcohol intake and cryptorchidism was non-linear. The curve suggested a change at ~60 g/week; however, this estimate was based on a limited number of studies and should not be regarded as an established threshold.</p><p><strong>Conclusions: </strong>Maternal average alcohol consumption was associated with higher odds of hypospadias, whereas moderate-to-severe alcohol consumption was associated with higher odds of cryptorchidism in a non-linear manner. Low-dose maternal alcohol consumption was not associated with cryptorchidism, but the inverse association observed for overall maternal alcohol consumption should be interpreted cautiously. Although the observed pattern may be consistent with a cumulative effect, we still recommend complete abstinence from alcohol during the periconceptional period and pregnancy.</p>","PeriodicalId":7407,"journal":{"name":"Alcohol and alcoholism","volume":"61 6","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149357042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jayant Mahadevan, Udit Panda, Abhishek Kumar Sharma, Daniel Paul Ritish Kavati, Likhitha Chandra, N Kubenthiran, Prabhat Kumar Chand, Pratima Murthy, Sanjeev Arora, Ashwani K Singal
{"title":"Training hepatologists in alcohol use disorder management: a pilot study.","authors":"Jayant Mahadevan, Udit Panda, Abhishek Kumar Sharma, Daniel Paul Ritish Kavati, Likhitha Chandra, N Kubenthiran, Prabhat Kumar Chand, Pratima Murthy, Sanjeev Arora, Ashwani K Singal","doi":"10.1093/alcalc/agag063","DOIUrl":"10.1093/alcalc/agag063","url":null,"abstract":"<p><strong>Background and aims: </strong>Alcohol use disorder (AUD) and alcohol associated liver disease (ALD) commonly co-occur, and integrated approaches to treatment are associated with better outcomes. This study aimed to develop an online module, the Program for Advanced Training of Hepatologists in Alcohol Use Disorder Management (PRATHAM), to enroll and train hepatologists, and to evaluate changes in participants' knowledge, attitudes, practices, and self-perceived competence pre- and post-training.</p><p><strong>Methods: </strong>This included identification of specific needs, establishing learning objectives, designing a curriculum, and developing didactic presentations for hepatologists. Interested participants were enrolled in the online module and were asked to submit pre-tests, clinical cases, and a post-test, which included an evaluation of knowledge, attitudes, practice, and self-perceived competence. Descriptive statistics and the Wilcoxon signed-rank test were used to analyze the data. An intention-to-treat analysis was used to address missing data.</p><p><strong>Results: </strong>An 8-week curriculum was developed for 18 hepatologists from five different countries. Of these, 17 completed the pre-test, and 11 filled out the post-test proforma. Eleven complex clinical cases were discussed. There was a significant improvement in the participants' knowledge, practice, and self-perceived competence pre- and post-training. However, no significant change in attitudes was noted.</p><p><strong>Conclusions: </strong>This study underscores the importance of tailored educational interventions in medical specialties such as hepatology, where practitioners frequently encounter patients with AUD. The significant improvements in practice, self-efficacy, and knowledge highlight the potential of targeted training programs to enhance patient care. Future studies could engage a more diverse group of hepatologists and evaluate patient outcomes.</p>","PeriodicalId":7407,"journal":{"name":"Alcohol and alcoholism","volume":"61 6","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13619337/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149073437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Heartbeat counting task performance in alcohol use disorder: a systematic review and meta-analysis.","authors":"Nicolás Guillermo González, Luisa Göde, Lucía Alba-Ferrara","doi":"10.1093/alcalc/agag061","DOIUrl":"10.1093/alcalc/agag061","url":null,"abstract":"<p><strong>Aims: </strong>Interoception has been proposed as a relevant process in alcohol use disorder (AUD), and studies using the heartbeat counting task (HCT) have often reported poorer performance in individuals with AUD than in healthy controls (HC). However, concerns about the construct validity of the HCT complicate interpretation of these findings. This systematic review and meta-analysis quantified the magnitude and consistency of group differences in HCT performance between adults with AUD and HC, without assuming that the task provides a process-pure measure of cardiac interoceptive accuracy.</p><p><strong>Methods: </strong>Eligible studies compared adults diagnosed with AUD with HC and reported sufficient HCT data to compute standardized mean differences. PubMed/MEDLINE, PsycINFO, Embase, and Web of Science were searched up to 4 November 2025. Study quality was assessed using an adapted Newcastle-Ottawa Scale. Hedges' g values were pooled using a random-effects model. The review received no specific external funding and was preregistered in PROSPERO [ID = CRD420251173904].</p><p><strong>Results: </strong>Six studies including 314 individuals with AUD and 324 HC were included. The pooled effect was moderate-to-large and negative, indicating lower HCT performance in AUD than HC, g = -0.79, 95% CI [-0.96, -0.63]. All included studies showed negative effect sizes, although the small evidence base limits certainty.</p><p><strong>Conclusions: </strong>Lower HCT performance appears to represent a preliminary but consistent task-level behavioral difference in AUD. These findings should not be interpreted as direct evidence of reduced cardiac interoceptive accuracy, but they support further investigation of whether HCT performance relates to clinically relevant AUD features.</p>","PeriodicalId":7407,"journal":{"name":"Alcohol and alcoholism","volume":"61 6","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149036038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alexandra C Wagner, Jeesun Jung, Carolina Vela, Emily Hui, Tyler Perlstein, Joshua Reitz, LaToya Sewell, Melanie L Schwandt, Nancy Diazgranados, Josephin Wagner, Daniel B Rosoff, Falk W Lohoff
{"title":"Alcohol use disorder with metabolic dysfunction is associated with adverse sleep outcomes in a US clinical cohort.","authors":"Alexandra C Wagner, Jeesun Jung, Carolina Vela, Emily Hui, Tyler Perlstein, Joshua Reitz, LaToya Sewell, Melanie L Schwandt, Nancy Diazgranados, Josephin Wagner, Daniel B Rosoff, Falk W Lohoff","doi":"10.1093/alcalc/agag070","DOIUrl":"10.1093/alcalc/agag070","url":null,"abstract":"<p><strong>Aim: </strong>Sleep is critical to health, yet its relationship to metabolic dysfunction (MD) in alcohol use disorder (AUD) remains understudied in US clinical populations.</p><p><strong>Methods: </strong>1359 participants were recruited through the Natural History Protocol at the National Institutes of Health and categorized into four groups: healthy controls (HC), individuals with MD only (metHC), individuals with current AUD without MD (AUD), and individuals with both current AUD and MD (metAUD). Sleep was assessed using the Pittsburgh Sleep Quality Index (PSQI). Multinomial logistic regression models were used to test associations between sleep metrics and group status, adjusting for age, race, and sex (Model 1), and additionally for education, income, and smoking status (Model 2). Additional models examined sleep outcomes by MD severity (mild, <3; severe, ≥3 criteria) among AUD.</p><p><strong>Results: </strong>Thousand two hundred twenty participants were included: 155 HC, 397 metHC, 77 AUD, and 591 metAUD. Adverse sleep outcomes were associated with increased odds of metHC, AUD, and metAUD groups compared to HC, with the strongest associations observed for metAUD across multiple PSQI domains. Each one-category increase in sleep disturbance was associated with an eleven-fold increase in odds of metAUD relative to HC (OR: 11.71, 95% CI, 6.90-19.86). Associations remained significant in Model 2. Sleep disturbance and daytime dysfunction were also associated with increased odds of severe MD compared to AUD-only (false discovery rate < 0.05).</p><p><strong>Conclusions: </strong>Adverse sleep outcomes were associated with increased odds of co-occurring MD in AUD, highlighting the clinical relevance of monitoring both sleep and metabolic health and the need for targeted intervention in this population.</p>","PeriodicalId":7407,"journal":{"name":"Alcohol and alcoholism","volume":"61 6","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13742133/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149357041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}